Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

Anupam Rasayan signs LOI with Prominent Japanese Multinational worth ~$90 Mn (~₹743 crores) to supply advance intermediatesqrcode

Apr. 15, 2024

Favorites Print
Apr. 15, 2024

Anupam Rasayan (NSE, BSE: ANURAS), one of India’s leading custom synthesis & speciality chemical players, has signed Letter of Intent worth revenue of ~$90 Mn (₹743 crores) over next 7 years with one of the leading Japanese company to supply two advance intermediates using fluorination chemistry. These molecules will be manufactured in the company's existing as well as soon to be commercialised fluorination plants.

Speaking about the LOI, Anand Desai, Managing Director of Anupam Rasayan, said "We are pleased to announce the signing of a Letter of Intent (LOI) with one of the largest Japanese players in Fluorochemicals. Anupam will be the first company in India to manufacture these key molecules within the country, with applications in both the pharmaceutical as well as engineering fluids, the signing of LOI also marks the addition of this new marquee customer.

Our Business Development Team has demonstrated exceptional proficiency in creating opportunities that aligns with our global expansion goals by cultivating strong ties with our Japanese counterparts. This landmark LOI not only expands and diversifies our customer base but also solidifies our position in the Japanese markets as one of the most reliable partners for supplying specialized molecules to global majors."


More from AgroNewsChange

Hot Topic More

I wanna post a press Comment


Subscribe Email: *
Mobile Number:  





Subscribe India Special Biweekly to send news related to your mailbox